Almirall, Barcelona Supercomputing Center, Nostrum Biodiscovery enter collaboration

Key takeaways:

• Almirall, Barcelona Supercomputing Center and Nostrum Biodiscovery have entered a research collaboration.
• The collaboration, called ARTIBAND, will research new therapies through artificial intelligence.

Almirall has entered a collaboration with the Barcelona Supercomputing Center and Nostrum Biodiscovery to research the use of artificial intelligence in dermatological therapies, the companies announced in a joint press release.

In this planned 3-year collaboration, named ARTIBAND, the companies will develop and train technology with data on the public domain then apply the technology to discover new protein-protein modulators.

“This new collaboration with [Barcelona Supercomputing Center] and Nostrum Biodiscovery marks a further step in our artificial intelligence and medical dermatology journey,” Francesc Fernández, PhD, Almirall’s data science director, said in the release. “Applying [artificial intelligence] to protein-protein modulator design not only discovers new therapeutic approaches but also fundamentally reshapes how we tackle and solve dermatological challenges. This endeavor represents a bold step forward in our commitment to improving lives through groundbreaking research and innovation.”

The Spanish Ministry of Science and Innovation decided to fund the project as part of the EU-funded Recover, Transformation and Resilience Plan.

“This collaboration, backed by cutting-edge generative artificial intelligence and machine learning, opens new avenues to advance dermatology research,” Víctor Guallar, PhD, chief scientific officer of Barcelona Supercomputing Center, said in the release.